SeqLL Provides First Quarter 2022 Financial Results and a Corporate Update
BILLERICA, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property, today announced its operating and financial results for the first quarter ended March 31, 2021, and provided a corporate update.
“We continue rapidly with our progress across multiple developmental programs around novel asset creation using SeqLL’s tSMS® platform,” said Daniel Jones, CEO, President, and Co-Founder of SeqLL. “Our team is focused on developing improved genetic tools for researchers, so they can better understand and detect the molecular mechanisms of disease which are essential for the continued development of new breakthroughs in genomic medicine.”
Recent Business Highlights
First Quarter 2022 Results and Financial Highlights
About True Single Molecule Sequencing (tSMS) Technology
About SeqLL, Inc.
Forward Looking Statements
Ashley R. Robinson
Small Cells: Why Smaller Means Faster!
Keynote Presentation by HCL - Open to all Badge Holders
Brunch Served in IoT Evolution Expo #TECHSUPERSHOW Expo Hall